Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT
Publication
, Conference
Martin, PL; Driscoll, TA; Szabolcs, P; Parikh, SH; Prasad, VK; Kurtzberg, J
Published in: Biology of Blood and Marrow Transplantation
February 2006
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2006
Volume
12
Issue
2
Start / End Page
127 / 127
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Martin, P. L., Driscoll, T. A., Szabolcs, P., Parikh, S. H., Prasad, V. K., & Kurtzberg, J. (2006). Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT. In Biology of Blood and Marrow Transplantation (Vol. 12, pp. 127–127). Elsevier BV. https://doi.org/10.1016/j.bbmt.2005.11.389
Martin, P. L., T. A. Driscoll, P. Szabolcs, S. H. Parikh, V. K. Prasad, and J. Kurtzberg. “Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT.” In Biology of Blood and Marrow Transplantation, 12:127–127. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.389.
Martin PL, Driscoll TA, Szabolcs P, Parikh SH, Prasad VK, Kurtzberg J. Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 127–127.
Martin, P. L., et al. “Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT.” Biology of Blood and Marrow Transplantation, vol. 12, no. 2, Elsevier BV, 2006, pp. 127–127. Crossref, doi:10.1016/j.bbmt.2005.11.389.
Martin PL, Driscoll TA, Szabolcs P, Parikh SH, Prasad VK, Kurtzberg J. Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT. Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 127–127.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2006
Volume
12
Issue
2
Start / End Page
127 / 127
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences